Other News To Note
• AVI BioPharma Inc., of Bothell, Wash., said it changed its name to Sarepta Therapeutics Inc. and its stock ticker to "SRPT." The firm also effected a 1-for-6 reverse stock split. The firm is working on RNA-based therapeutics, including lead drug eteplirsen for Duchenne's muscular dystrophy.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST